Aptevo Therapeutics Inc (NQ: APVO )

18.28 USD UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 27, 2021 Add to My Watchlist

Price and Volume

Volume	0
Open	18.28
Bid (Size)	10.01 (1)
Ask (Size)	20.49 (2)
Prev. Close	18.28
Today's Range	18.28 - 18.28
52wk Range	6.170 - 60.00
Shares Outstanding	4,449,535
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Aptevo Therapeutics' Chief Scientific Officer, Jane Gross, PhD, to Present at Upcoming Cambridge Health Institute PEGS Virtual Conference

July 16, 2021

Aptevo Therapeutics' Scientists to Present At Virtual Cell Engager Summit

June 30, 2021

Performance

YTD	-50.83%	-50.83%
1 Month	-23.67%	-23.67%
3 Month	-33.50%	-33.50%
6 Month	-50.01%	-50.01%
1 Year	+113.55%	+113.55%

More News

Aptevo Therapeutics Announces Inclusion in the Russell Microcap(R) Index

June 29, 2021

Aptevo Therapeutics Announces Expansion Phase of Lead Anti-Leukemia Drug APVO436 in Adult Patients with Acute Myeloid Leukemia

May 27, 2021

Aptevo Therapeutics Reports Positive Phase 1 Clinical Data for Its Lead Leukemia Drug Candidate APVO436 in Adults With Relapsed Acute Myeloid Leukemia

May 26, 2021

Aptevo Therapeutics Reports First Quarter 2021 Financial Results

May 11, 2021

Aptevo Therapeutics to Present at the American Association for Cancer Research Virtual Annual Meeting

April 09, 2021

Friday Sector Leaders: Water Utilities, Biotechnology Stocks

July 16, 2021

Aptevo Therapeutics Reports 2020 Financial Results and Provides Business Update

March 31, 2021

12 Health Care Stocks Moving In Tuesday's Intraday Session

June 22, 2021

Mid-Afternoon Market Update: Dow Jumps Over 500 Points; Lydall Shares Spike Higher

June 21, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.